The Structural Disease Center

Filter Your Results

 

News

 

Early Feasibility Study Begins for Ancora Heart's AccuCinch Transcatheter Heart Failure Therapy

June 3, 2019 -- Ancora Heart, Inc. announced the first patient was enrolled in a United States early feasibility study evaluating the company's AccuCinch ventricular repai…

Results Presented for AMI Patients Treated Early With Cell Therapy Delivered Using Biocardia’s Helix System

June 3, 2019 -- BioCardia, Inc. announced the presentation of results from a study of the company’s Helix biotherapeutic delivery system for cell therapy used to treat p…

Long-Term Follow-Up Data Published for Occlutech's Figulla Percutaneous PFO Occluder

May 13, 2019 -- A Dutch analysis of the safety and efficacy of the Figulla patent foramen ovale (PFO) occluder (Occlutech International AB) with long-term follow-up of approxi…

United States Feasibility Study Begins for Conformal LAA Seal for Stroke Prevention

April 9, 2019 -- Conformal Medical, Inc. announced the first human use of its left atrial appendage (LAA) occlusion technology for the prevention of stroke in patients with at…

SCAI Publishes Recommendations for Use of PFO Closure Technologies

April 1, 2019 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced the publication of an expert consensus statement that provides recommendations f…

FEops Heartguide Platform Receives CE Mark Approval for Planning Structural Heart Interventions

April 1, 2019 -- FEops announced CE Mark approval for the Heartguide procedural planning environment for structural heart interventions. The technology provides physicians wit…

Boston Scientific's Watchman FLX Left Atrial Appendage Closure Device Approved in Europe

March 13, 2019 -- Boston Scientific Corporation announced it has received European CE Mark approval of the next-generation Watchman FLX left atrial appendage closure (LAAC) de…

Micro Interventional Devices, Inc. Enters Strategic Alliance With Oscor, Inc.

March 11, 2019 -- Micro Interventional Devices, Inc. (MID) and Oscor, Inc. announced a strategic alliance to develop and commercialize solutions to structural heart disease, s…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.